Cancer genetics and implications for clinical management

Jamieson, N. B. , Chang, D. K. and Biankin, A. V. (2015) Cancer genetics and implications for clinical management. Surgical Clinics of North America, 95(5), pp. 919-934. (doi: 10.1016/j.suc.2015.05.003) (PMID:26315514)

Full text not currently available from Enlighten.


There is now compelling evidence that the molecular heterogeneity of cancer is associated with disparate phenotypes with variable outcomes and therapeutic responsiveness to therapy in histologically indistinguishable cancers. This diversity may explain why conventional clinical trial designs have mostly failed to show efficacy when patients are enrolled in an unselected fashion. Knowledge of the molecular phenotype has the potential to improve therapeutic selection and hence the early delivery of the optimal therapeutic regimen. Resolution of the challenges associated with a more stratified approach to health care will ensure more precise diagnostics and enhance therapeutic selection, which will improve overall outcomes.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Jamieson, Dr Nigel and Biankin, Professor Andrew and Chang, Professor David
Authors: Jamieson, N. B., Chang, D. K., and Biankin, A. V.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Surgical Clinics of North America
Publisher:W.B. Saunders Co.
ISSN (Online):1558-3171

University Staff: Request a correction | Enlighten Editors: Update this record